Federal Register / Vol. 82, No. 187 / Thursday, September 28, 2017 / Notices 45299 

Panels Function 

Ophthalmic Devices Panel .............. Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes appropriate recommendations to the Commissioner of Food and 

Drugs. 

II. Qualifications 

Persons nominated for the device 

panels should be full-time employees of 

firms that manufacture products that 

would come before the panel, or 

consulting firms that represent 

manufacturers, or have similar 

appropriate ties to industry. 

III. Selection Procedure 

Any industry organization interested 

in participating in the selection of an 

appropriate nonvoting member to 

represent industry interests should send 

a letter stating that interest to the FDA 

contact (see FOR FURTHER INFORMATION

CONTACT) within 30 days of publication 

of this document (see DATES). Within the 

subsequent 30 days, FDA will send a 

letter to each organization that has 

expressed an interest, attaching a 

complete list of all such organizations; 

and a list of all nominees along with 

their current resumes. The letter will 

also state that it is the responsibility of 

the interested organizations to confer 

with one another and to select a 

candidate, within 60 days after the 

receipt of the FDA letter, to serve as the 

nonvoting member to represent industry 

interests for a particular device panel. 

The interested organizations are not 

bound by the list of nominees in 

selecting a candidate. However, if no 

individual is selected within 60 days, 

the Commissioner will select the 

nonvoting member to represent industry 

interests. 

IV. Application Procedure 

Individuals may self-nominate and/or 

an organization may nominate one or 

more individuals to serve as a nonvoting 

industry representative. Contact 

information, a current curriculum vitae, 

and the name of the panel of interest 

should be sent to the FDA Advisory 

Committee Membership Nomination 

Portal (see ADDRESSES) within 30 days of 

publication of this document (see 

DATES). FDA will forward all 

nominations to the organizations 

expressing interest in participating in 

the selection process for the particular 

device panels listed in the table. 

(Persons who nominate themselves as 

nonvoting industry representatives will 

not participate in the selection process). 

FDA seeks to include the views of 

women and men, members of all racial 

and ethnic groups, and individuals with 

and without disabilities on its advisory 

committees and, therefore encourages 

nominations of appropriately qualified 

candidates from these groups. 

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2) and 21 CFR part 14, 

relating to advisory committees. 

Dated: September 22, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–20778 Filed 9–27–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990–0330] 

Agency Information Collection 

Request. 60-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before November 27, 

2017. 

ADDRESSES: Submit your comments to 

Sherrette.Funn@hhs.gov or by calling 

(202)795–7714. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 0990–0330–60D 

and project title for reference, to 

Sherrette.funn@hhs.gov, the Reports 

Clearance Officer Sherrette Funn, call 

202–795–7714. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title: Appellant Climate Survey, 

Revision. 

Abstract: The Office of Medicare 

Hearings and Appeals (OMHA) requests 

revision to a previously approved 

information collection request from the 

Office of Management and Budget 

(OMB). The annual OMHA Appellant 

Climate Survey is a survey of Medicare 

beneficiaries, providers, suppliers, or 

their representatives who participated 

in a hearing before an Administrative 

Law Judge (ALJ) from OMHA. 

Appellants dissatisfied with the 

outcome of their Level 2 Medicare 

appeal may request a hearing before an 

OMHA ALJ. The Appellant Climate 

Survey will be used to measure 

appellant satisfaction with their OMHA 

appeals experience, as opposed to their 

satisfaction with a specific ruling. 

OMHA was established by the Medicare 

Prescription Drug, Improvement, and 

Modernization Act (MMA) of 2003 (Pub. 

L. 108–173) and became operational on 

July 1, 2005. The MMA legislation and 

implementing regulations issued on 

March 8, 2007 instituted a number of 

changes in the appeals process. The 

MMA legislation also directed HHS to 

consider the feasibility of conducting 

hearings using telephone or videoteleconference (VTC) technologies. In 

carrying out this mandate, OMHA 

makes use of both teleconferencing and 

VTC to provide appellants with a vast 

nationwide network of access points for 

hearings close to their homes. The first 

3-year administration cycle of the 

OMHA survey began in fiscal year (FY) 

2008, a second 3-year cycle began in 

FY2011, and third 3-year cycle began in 

FY2014. The survey will continue to be 

conducted annually over a 3-year period 

with the next data collection cycle 

beginning in FY2018. Data collection 

instruments and recruitment materials 

will be offered in English and Spanish. 

Total burden for survey respondents is 

100.00 hours each year. 

Affected Public: Survey respondents 

will consist of Medicare beneficiaries 

and non-beneficiaries (i.e., providers, 

suppliers), who participated in a 

hearing before an OMHA ALJ. OMHA 

will draw a representative, nonredundant sample of appellants whose 

45300 Federal Register / Vol. 82, No. 187 / Thursday, September 28, 2017 / Notices 

cases have been closed in the last 6 

months. 

Terry S. Clark, 

Office of the Secretary, Asst. Paperwork 

Reduction Act Reports Clearance Officer. 

[FR Doc. 2017–20738 Filed 9–27–17; 8:45 am] 

BILLING CODE 4150–46–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Secretary’s Advisory 

Committee on National Health 

Promotion and Disease Prevention 

Objectives for 2030 

AGENCY: Office of Disease Prevention 

and Health Promotion, Office of the 

Assistant Secretary for Health, Office of 

the Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

announces the next federal advisory 

committee meeting regarding the 

development of national health 

promotion and disease prevention 

objectives for 2030. This meeting will be 

held online via webinar and is open to 

the public. The Committee will discuss 

the nation’s health promotion and 

disease prevention objectives and will 

provide recommendations to improve 

health status and reduce health risks for 

the nation by the year 2030. The 

Committee will advise the Secretary on 

the Healthy People 2030 mission, 

vision, framework, and organizational 

structure. The Committee will provide 

advice regarding criteria for identifying 

a more focused set of measurable, 

nationally representative objectives. The 

Committee’s advice must assist the 

Secretary in reducing the number of 

objectives while ensuring that the 

selection criteria identifies the most 

critical public health issues that are 

high-impact priorities supported by 

current national data. 

DATES: The Committee will meet on 

October 16, 2017, from 1:00 p.m. to 3:00 

p.m. Eastern Time (ET). 

ADDRESSES: The meeting will be held 

online via webinar. To register to attend 

the meeting, please visit the Healthy 

People Web site at http://

www.healthypeople.gov. 

FOR FURTHER INFORMATION CONTACT: 

Emmeline Ochiai, Designated Federal 

Official, Secretary’s Advisory 

Committee on National Health 

Promotion and Disease Prevention 

Objectives for 2030, U.S. Department of 

Health and Human Services, Office of 

the Assistant Secretary for Health, 

Office of Disease Prevention and Health 

Promotion, 1101 Wootton Parkway, 

Room LL–100, Rockville, MD 20852, 

(240) 453–8280 (telephone), (240) 453– 

8281 (fax). Additional information is 

available on the Healthy People Web 

site at http://www.healthypeople.gov. 

SUPPLEMENTARY INFORMATION: The 

names and biographies of the 

Committee members are available at 

https://www.healthypeople.gov/2020/ 

about/history-development/healthypeople-2030-advisory-committee. 

Purpose of Meeting: Through the 

Healthy People initiative, HHS leverages 

scientific insights and lessons from the 

past decade, along with new knowledge 

of current data, trends, and innovations, 

to develop the next iteration of national 

health promotion and disease 

prevention objectives. Healthy People 

provides science-based, 10-year national 

objectives for promoting health and 

preventing disease. Since 1979, Healthy 

People has set and monitored national 

health objectives that meet a broad 

range of health needs, encourage 

collaboration across sectors, guide 

individuals toward making informed 

health decisions, and measure the 

impact of our prevention and health 

promotion activities. Healthy People 

2030 health objectives will reflect 

assessments of major risks to health and 

wellness, changing public health 

priorities, and emerging technologies 

related to our nation’s health 

preparedness and prevention. 

Public Participation at Meeting: 

Members of the public are invited to 

join the online Committee meeting. 

There will be no opportunity for oral 

public comments during this online 

Committee meeting. However, written 

comments are welcome throughout the 

entire development process of the 

national health promotion and disease 

prevention objectives for 2030 and may 

be emailed to HP2030@hhs.gov. 

To join the Committee meeting, 

individuals must pre-register at the 

Healthy People Web site at http://

www.healthypeople.gov. Participation in 

the meeting is limited. Registrations will 

be accepted until maximum webinar 

capacity is reached and must be 

completed by 9:00 a.m. ET on October 

13, 2017. A waiting list will be 

maintained should registrations exceed 

capacity and those individuals will be 

contacted as additional space for the 

meeting becomes available. Registration 

questions may be directed to: Kate 

Fromknecht at fromknecht-kate@

norc.org or (301) 634–9384. 

Authority: 42 U.S.C. 217a. The 

Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2030 is 

governed by provisions of the Federal 

Advisory Committee Act (FACA), Public 

Law 92–463, as amended (5 U.S.C., 

App.) which sets forth standards for the 

formation and use of federal advisory 

committees. 

Dated: September 22, 2017. 

Don Wright, 

Deputy Assistant Secretary for Health, 

(Disease Prevention and Health Promotion). 

[FR Doc. 2017–20781 Filed 9–27–17; 8:45 am] 

BILLING CODE 4150–32–P 


EN28SE17.003</GPH>